Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.35 - $15.85 $391,499 - $1.43 Million
-90,000 Reduced 78.26%
25,000 $283,000
Q1 2022

May 16, 2022

BUY
$4.55 - $6.41 $523,250 - $737,150
115,000 New
115,000 $555,000
Q2 2021

Aug 16, 2021

SELL
$7.24 - $11.2 $362,000 - $560,000
-50,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$8.05 - $20.78 $402,500 - $1.04 Million
50,000 New
50,000 $539,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $53.7M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.